Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Journal of Biomedical Science · 09.01.2025 · 32 (1)
DOI: 10.1186/s12929-024-01099-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biomedical Science, online erschienen am 09.01.2025. Verfasst von Zhipeng Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, 3084, Australia. Zhipeng.Cao@onjcri.org.au. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Neoplasms. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 456 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, National Imaging Facility.
Abstract (Originalsprache)
Research into cancer treatment has been mainly focused on developing therapies to directly target cancer cells. Over the past decade, extensive studies have revealed critical roles of the tumour microenvironment (TME) in cancer initiation, progression, and drug resistance. Notably, cancer-associated fibroblasts (CAFs) have emerged as one of the primary contributors in shaping TME, creating a favourable environment for cancer development. Many preclinical studies have identified promising targets on CAFs, demonstrating remarkable efficacy of some CAF-targeted treatments in preclinical models. Encouraged by these compelling findings, therapeutic strategies have now advanced into clinical evaluation. We aim to provide a comprehensive review of relevant subjects on CAFs, including CAF-related markers and targets, their multifaceted roles, and current landscape of ongoing clinical trials. This knowledge can guide future research on CAFs and advocate for clinical investigations targeting CAFs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, 3084, Australia. Zhipeng.Cao@onjcri.org.au.
- School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia. Zhipeng.Cao@onjcri.org.au.
- Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, 3084, Australia. Zhipeng.Cao@onjcri.org.au.
- Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, 3084, Australia.
- School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.
- Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia.
Förderung
- National Health and Medical Research Council
- National Imaging Facility
Zitieren
APA
Cao, Z., Quazi, S., Arora, S., Osellame, L. D., Burvenich, I. J., Janes, P. W., & Scott, A. M. (2025). Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects. Journal of Biomedical Science, 32(1). https://doi.org/10.1186/s12929-024-01099-2
Vancouver
Cao Z, Quazi S, Arora S, Osellame LD, Burvenich IJ, Janes PW, et al. Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects. Journal of Biomedical Science. 2025;32(1). doi:10.1186/s12929-024-01099-2
BibTeX
@article{Cao2025,
author = {Cao, Zhipeng and Quazi, Sadia and Arora, Sakshi and Osellame, Laura D and Burvenich, Ingrid J and Janes, Peter W and Scott, Andrew M},
title = {Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects},
journal = {Journal of Biomedical Science},
year = {2025},
volume = {32},
number = {1},
doi = {10.1186/s12929-024-01099-2}
}
EUVIMED